Insider Spends US$204k Buying More Shares In EHealth
Insider Spends US$204k Buying More Shares In EHealth
Investors who take an interest in eHealth, Inc. (NASDAQ:EHTH) should definitely note that the CEO & Director, Francis Soistman, recently paid US$4.07 per share to buy US$204k worth of the stock. That's a very decent purchase to our minds and it grew their holding by a solid 10%.
对于对易康公司(纳斯达克:EHTH)感兴趣的投资者,应该注意到该公司的首席执行官兼董事Francis Soistman最近以4.07美元每股的价格购买了20.4万美元的股票。在我们看来,这是一笔非常不错的购买,他们的持股增加了稳定的10%。
The Last 12 Months Of Insider Transactions At eHealth
过去12个月易康公司的内部交易记录
Notably, that recent purchase by Francis Soistman is the biggest insider purchase of eHealth shares that we've seen in the last year. That means that an insider was happy to buy shares at around the current price of US$4.45. That means they have been optimistic about the company in the past, though they may have changed their mind. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. Happily, the eHealth insiders decided to buy shares at close to current prices.
值得注意的是,Francis Soistman最近的购买是我们在过去一年中看到的易康公司股票最大的内部人士购买。这意味着内部人士愿意以约4.45美元的现价购买股票。这意味着他们过去一直对该公司持乐观态度,但他们的想法可能已经改变。我们总是喜欢看到内部人士购买,但值得注意的是,如果那些购买是在远低于今天的股价时进行的,因为折扣到价值的折让可能随着上涨的价格而缩小。令人高兴的是,易康公司内部人士决定以接近现价的价格购买股票。
In the last twelve months eHealth insiders were buying shares, but not selling. Their average price was about US$4.56. This is nice to see since it implies that insiders might see value around current prices. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
在过去的12个月中,易康公司的内部人员购买了股票,但没有出售。他们的平均价格约为4.56美元。这是令人高兴的,因为这意味着内部人士可能看到当前价格周围的价值。下面的图表显示了过去一年中公司和个人的内部交易。如果您想知道究竟是谁以多少钱在何时卖出的,只需点击下面的图表即可!
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240812/0-21fb1d4b7251e9f8a7b9ffd59a35861f-0-87397d469f30178b994b45e251f82c5b.png/big)
There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this free list of companies. (Hint: insiders have been buying them).
内部人士正在购买的股票是无数的。如果您喜欢投资于较少知名公司,您可以查看此免费的公司列表(提示:内部人士一直在购买它们)。
Does eHealth Boast High Insider Ownership?
易康公司是否拥有高内部持股率?
Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 4.8% of eHealth shares, worth about US$6.3m, according to our data. We do generally prefer see higher levels of insider ownership.
许多投资者喜欢检查公司有多少股份是由内部人员拥有的。高内部持股往往使公司领导更加关注股东的利益。根据我们的数据,内部人员拥有易康公司的4.8%股份,价值约630万美元。我们通常更喜欢看到更高水平的内部持股。
What Might The Insider Transactions At eHealth Tell Us?
易康公司内部交易可能告诉我们什么?
It's certainly positive to see the recent insider purchases. And an analysis of the transactions over the last year also gives us confidence. But we don't feel the same about the fact the company is making losses. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactions suggests that eHealth insiders are expecting a bright future. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. In terms of investment risks, we've identified 3 warning signs with eHealth and understanding them should be part of your investment process.
最近的内部人士购买股票肯定是积极的。过去一年的交易分析也增加了我们的信心。但我们对公司亏损的事实并不感到满意。我们当然希望看到更高水平的内部持股,但内部交易的分析表明,易康公司内部人士预期有一个辉煌明天。因此,虽然了解内部人员的买卖非常有帮助,但了解一个特定公司面临的风险也很有帮助。在投资风险方面,我们已确定3个与易康公司有关的警示信号,并且了解它们应该是您的投资过程的一部分。
Of course eHealth may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
当然,易康公司可能不是最好的股票买入选择。因此,您可能希望查看这个免费的高质量股票的收藏。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。